Literature DB >> 9070574

Cardiovascular effects of a trandolapril/verapamil combination in patients with mild to moderate essential hypertension.

F C Aepfelbacher1, F H Messerli, E Nunez, L Michalewicz.   

Abstract

The cardiovascular effects of a combination of trandolapril and verapamil were evaluated in 14 patients with mild to moderate essential hypertension. This combination therapy decreased arterial pressure mainly through a decrease in total peripheral resistance without causing an increase in heart rate or cardiac output: left ventricular mass was significantly reduced, cardiac systolic function improved, and plasma volume and renal blood flow remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070574     DOI: 10.1016/s0002-9149(96)00883-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.

Authors:  Neil A Reynolds; Antona J Wagstaff; Susan J Keam
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

Authors:  Richard B R Muijsers; Monique P Curran; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Fixed combination verapamil SR/trandolapril.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

4.  Efficacy of a fixed-dose combination of trandolapril-verapamil in patients with stage 2 hypertension inadequately controlled by monotherapy.

Authors:  Alberto Francisco Rubio-Guerra; Adalberto Arceo-Navarro; José Juan Lozano-Nuevo; Germán Vargas-Ayala; Leticia Rodríguez-López; Luz María Ramos-Brizuela
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

5.  Effects of verapamil slow release plus trandolapril combination therapy on essential hypertension.

Authors:  Ulver Derici; Sukru Sindel; Turgay Arinsoy; Musa Bali; Berna Goker; Mustafa Cemri; Enver Hasanoglu
Journal:  Curr Ther Res Clin Exp       Date:  2003-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.